BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21315352)

  • 1. Long-term treatment with low-dose metoprolol CR/XL is associated with increased plaque echogenicity: the Beta-blocker Cholesterol-lowering Asymptomatic Plaque Study (BCAPS).
    Ostling G; Gonçalves I; Wikstrand J; Berglund G; Nilsson J; Hedblad B
    Atherosclerosis; 2011 Apr; 215(2):440-5. PubMed ID: 21315352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: Main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS).
    Hedblad B; Wikstrand J; Janzon L; Wedel H; Berglund G
    Circulation; 2001 Apr; 103(13):1721-6. PubMed ID: 11282901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of controlled release/extended release metoprolol on carotid intima-media thickness in patients with hypercholesterolemia: a 3-year randomized study.
    Wiklund O; Hulthe J; Wikstrand J; Schmidt C; Olofsson SO; Bondjers G
    Stroke; 2002 Feb; 33(2):572-7. PubMed ID: 11823672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiatherosclerotic effects of beta-blockers.
    Wikstrand J; Berglund G; Hedblad B; Hulthe J
    Am J Cardiol; 2003 Jun; 91(12A):25H-29H. PubMed ID: 12818732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fasting levels of growth hormone are associated with carotid intima media thickness but are not affected by fluvastatin treatment.
    Hallengren E; Almgren P; Rosvall M; Östling G; Persson M; Bergmann A; Struck J; Engström G; Hedblad B; Melander O
    BMC Cardiovasc Disord; 2017 May; 17(1):125. PubMed ID: 28511669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin treatment and carotid plaque morphology in first-ever atherosclerotic transient ischemic attack/stroke: a case-control study.
    Marchione P; Vento C; Morreale M; Izzo C; Maugeri A; Manuppella F; Romeo T; Giacomini P
    J Stroke Cerebrovasc Dis; 2015 Jan; 24(1):138-43. PubMed ID: 25440329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in echogenicity of echolucent carotid plaques after treatment with total triterpenic fraction of Centella asiatica: a prospective, placebo-controlled, randomized trial.
    Cesarone MR; Belcaro G; Nicolaides AN; Geroulakos G; Bucci M; Dugall M; De Sanctis MT; Incandela L; Griffin M; Sabetai M
    Angiology; 2001 Oct; 52 Suppl 2():S19-25. PubMed ID: 11666118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of carotid plaque echogenicity based on the integral of the cumulative probability distribution using gray-scale ultrasound images.
    Huang X; Zhang Y; Meng L; Abbott D; Qian M; Wong KKL; Zheng R; Zheng H; Niu L
    PLoS One; 2017; 12(10):e0185261. PubMed ID: 28977008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pharmacokinetic and pharmacodynamic comparison of immediate-release metoprolol and extended-release metoprolol CR/XL in patients with suspected acute myocardial infarction: a randomized, open-label study.
    Karlson BW; Dellborg M; Gullestad L; Aberg J; Sugg J; Herlitz J
    Cardiology; 2014; 127(2):73-82. PubMed ID: 24247812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carotid plaque characteristics on magnetic resonance plaque imaging following long-term cilostazol therapy.
    Yamaguchi Oura M; Sasaki M; Ohba H; Narumi S; Oura K; Uwano I; Terayama Y
    J Stroke Cerebrovasc Dis; 2014 Oct; 23(9):2425-30. PubMed ID: 25174559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of grey scale median (GSM) measurement in ultrasound images of human carotid plaques using two different softwares.
    Östling G; Persson M; Hedblad B; Gonçalves I
    Clin Physiol Funct Imaging; 2013 Nov; 33(6):431-5. PubMed ID: 23701450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF).
    Lancet; 1999 Jun; 353(9169):2001-7. PubMed ID: 10376614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF).
    Wikstrand J; Hjalmarson A; Waagstein F; Fagerberg B; Goldstein S; Kjekshus J; Wedel H;
    J Am Coll Cardiol; 2002 Aug; 40(3):491-8. PubMed ID: 12142116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of metoprolol CR/XL on exercise tolerance in chronic heart failure - a substudy to the MERIT-HF trial.
    Gullestad L; Manhenke C; Aarsland T; Skårdal R; Fagertun H; Wikstrand J; Kjekshus J
    Eur J Heart Fail; 2001 Aug; 3(4):463-8. PubMed ID: 11511433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of combined treatment with beta 1-selective receptor antagonists and lipid-lowering drugs on fat metabolism and measures of fatigue during moderate intensity exercise: a placebo-controlled study in healthy subjects.
    Eagles CJ; Kendall MJ
    Br J Clin Pharmacol; 1997 Mar; 43(3):291-300. PubMed ID: 9088584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated high-density lipoprotein cholesterol levels are protective against plaque progression: a follow-up study of 1952 persons with carotid atherosclerosis the Tromsø study.
    Johnsen SH; Mathiesen EB; Fosse E; Joakimsen O; Stensland-Bugge E; Njølstad I; Arnesen E
    Circulation; 2005 Jul; 112(4):498-504. PubMed ID: 16027250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metoprolol: a review of its use in chronic heart failure.
    Prakash A; Markham A
    Drugs; 2000 Sep; 60(3):647-78. PubMed ID: 11030472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metoprolol controlled release/extended release in patients with severe heart failure: analysis of the experience in the MERIT-HF study.
    Goldstein S; Fagerberg B; Hjalmarson A ; Kjekshus J; Waagstein F; Wedel H; Wikstrand J;
    J Am Coll Cardiol; 2001 Oct; 38(4):932-8. PubMed ID: 11583861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of ultrasonic tissue characterization of carotid plaque in the prediction of cardiovascular events in diabetic patients.
    Irie Y; Katakami N; Kaneto H; Takahara M; Nishio M; Kasami R; Sakamoto K; Umayahara Y; Sumitsuji S; Ueda Y; Kosugi K; Shimomura I
    Atherosclerosis; 2013 Oct; 230(2):399-405. PubMed ID: 24075774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Marker Variability in Subclinical Carotid Plaques Based on Ultrasound is Influenced by Cardiac Phase, Echogenicity and Size.
    Nyman E; Lindqvist P; Näslund U; Grönlund C
    Ultrasound Med Biol; 2018 Aug; 44(8):1742-1750. PubMed ID: 29735317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.